FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1110.50

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1110.50
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1110.50/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50
Version20220219
Statusactive
Date2022-02-19T01:06:51-05:00
NameRivaroxabanForVTEProphylaxis
TitleRivaroxaban for VTE Prophylaxis
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for medications of rivaroxaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for oral forms of rivaroxaban.),(Exclusion Criteria: No exclusions.)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1248.204VTE Prophylaxis

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1110.50",
  "meta": {
    "versionId": "20",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "TJC EH Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
      "valueString": "VTE-01,VTE-02"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-05"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2022-02-19"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1110.50"
    }
  ],
  "version": "20220219",
  "name": "RivaroxabanForVTEProphylaxis",
  "title": "Rivaroxaban for VTE Prophylaxis",
  "status": "active",
  "experimental": false,
  "date": "2022-02-19T01:06:51-05:00",
  "publisher": "TJC EH Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for medications of rivaroxaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for oral forms of rivaroxaban.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1114198",
            "display": "rivaroxaban 10 MG Oral Tablet"
          },
          {
            "code": "1232082",
            "display": "rivaroxaban 15 MG Oral Tablet"
          },
          {
            "code": "1232086",
            "display": "rivaroxaban 20 MG Oral Tablet"
          },
          {
            "code": "1549682",
            "display": "{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"
          },
          {
            "code": "2059015",
            "display": "rivaroxaban 2.5 MG Oral Tablet"
          },
          {
            "code": "2588062",
            "display": "rivaroxaban 155 MG Granules for Oral Suspension"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:729500c7-b3cd-4d0e-84e2-d9a2337eb590",
    "timestamp": "2025-05-23T18:13:58-04:00",
    "total": 6,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1114198",
        "display": "rivaroxaban 10 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1232082",
        "display": "rivaroxaban 15 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1232086",
        "display": "rivaroxaban 20 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1549682",
        "display": "{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2059015",
        "display": "rivaroxaban 2.5 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588062",
        "display": "rivaroxaban 1 MG/ML Oral Suspension"
      }
    ]
  }
}